United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 279,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "16f8af47-5aa4-4e2d-a827-8df98a445583",
"title": "ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation -- EGBN",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on b",
"keywords": "GuruFocus, Article, News, Marketwired, EGBN",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on beha...",
"url": "https://www.gurufocus.com/news/2900037/rosen-skilled-investor-counsel-encourages-eagle-bancorp-inc-investors-to-inquire-about-securities-class-action-investigation-egbn",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-01T01:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EGBN",
"name": "Eagle Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 101.31907,
"sentiment_score": 0.1625,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+344 characters]",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Eagle</em>[+238 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "WHAT IS THIS ABOUT: On April 23, 2025, a[+168 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, SKILLED INVESTOR COUNSEL, Encourages <em>Eagle</em> <em>Bancorp</em>, <em>Inc</em>. Investors to Inquire About Securities Class Action Investigation -- EGBN",
"sentiment": 0.6249,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "19597493-086a-4e7b-a5f4-c2a27046ea8e",
"title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- BITF",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. ( BITF)",
"keywords": "GuruFocus, Article, News, Marketwired, BITF",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. ( BITF) be...",
"url": "https://www.gurufocus.com/news/2900006/rosen-global-investor-counsel-encourages-bitfarms-ltd-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-bitf",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BITF",
"name": "Bitfarms Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 121.291916,
"sentiment_score": 0.6331,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+291 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Bitfarms</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- <em>BITF</em>",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "BFARF",
"name": "Bitfarms Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 90.534485,
"sentiment_score": 0.6331,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+282 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Bitfarms</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- BITF",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "BITF.V",
"name": "Bitfarms Ltd.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Financial Services",
"match_score": 90.52942,
"sentiment_score": 0.6331,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+282 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Bitfarms</em> <em>Ltd</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- BITF",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "a7aa2fab-c747-4530-aeff-a6b394f0f154",
"title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, In",
"keywords": "GuruFocus, Article, News, Marketwired, CAR",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. ...",
"url": "https://www.gurufocus.com/news/2900000/rosen-global-investor-counsel-encourages-avis-budget-group-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-car",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T19:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0HK4.L",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 100.11216,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 100.11156,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR.BA",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Industrials",
"match_score": 100.11064,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR.MX",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Industrials",
"match_score": 100.112854,
"sentiment_score": 0.0944,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+314 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Avis</em> [+293 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the la[+330 characters]",
"sentiment": -0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "of Avis Budget’s vehicles in the Ameri[+337 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Avis</em> <em>Budget</em[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages <em>Avis</em> <em>Budget</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "f39fb8da-d117-432e-8261-8e9b072404bb",
"title": "Trump administration cancels $3.7B in clean energy projects, including at Exxon's Baytown",
"description": "The U.S. Department of Energy terminated 24 awards for clean energy projects totaling $3.7B that were issued under the Biden administration, including to an Exxon refinery complex in Texas.",
"keywords": "",
"snippet": "The U.S. Department of Energy said Friday it terminated 24 awards for clean energy projects totaling $3.7B that were issued under the Biden administration, incl...",
"url": "https://seekingalpha.com/news/4454029-trump-administration-cancels-3_7b-in-clean-energy-projects-including-at-exxons-baytown",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/167231386/image_167231386.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-06-01T00:48:16.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "XOM",
"name": "Exxon Mobil Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 40.07833,
"sentiment_score": 0.836,
"highlights": [
{
"highlight": "Department of Energy said Friday it term[+232 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "70ae7800-aa89-4018-9e11-60a31a50e591",
"title": "Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial",
"description": "Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at the 2025 ASCO Annual Meeting, marking the first therapy to show statistically...",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/zai-lab-limited-zlab-novocure-limited-nvcrs-ttfields-therapy-succeeds-in-phase-3-trial-1545340/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/16123420/IMMX-insidermonkey-1702748058443.jpg",
"language": "en",
"published_at": "2025-06-01T00:22:25.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVCR",
"name": "NovoCure Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.346085,
"sentiment_score": 0.3182,
"highlights": [
{
"highlight": "Zai Lab Limited (ZLAB) & <em>NovoCure</em> <em>Limited</em> (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "ZLAB",
"name": "Zai Lab Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 128.13614,
"sentiment_score": 0.3182,
"highlights": [
{
"highlight": "<em>Zai</em> <em>Lab</em> <em>Limited</em> (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial",
"sentiment": 0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "11de2160-7aa9-4192-a34c-b89104f8d9b6",
"title": "Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"description": "The Phase 3 PANOVA-3 trial shows TTFields therapy significantly improves overall survival in pancreatic cancer. TTFields therapy demonstrated a 2-month",
"keywords": "GuruFocus, Article, News, GuruFocus News, ZLAB",
"snippet": "The Phase 3 PANOVA-3 trial shows TTFields therapy significantly improves overall survival in pancreatic cancer.\n\nTTFields therapy demonstrated a 2-month increas...",
"url": "https://www.gurufocus.com/news/2900009/zai-lab-and-novocure-announce-results-from-the-phase-3-panova3-trial-of-tumor-treating-fields-ttfields-therapy-for-pancreatic-cancer-to-be-presented-at-2025-asco-annual-meeting-zlab-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BBJG.png?20",
"language": "en",
"published_at": "2025-05-31T20:15:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZLAB",
"name": "Zai Lab Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.19176,
"sentiment_score": -0.7196,
"highlights": [
{
"highlight": "<em>Zai</em> <em>Lab</em> <em>Limited</e[+325 characters]",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zai</em> <em>Lab</em> and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"sentiment": -0.7906,
"highlighted_in": "title"
}
]
},
{
"symbol": "ZLABN.MX",
"name": "Zai Lab Limited",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 58.175102,
"sentiment_score": -0.7196,
"highlights": [
{
"highlight": "<em>Zai</em> <em>Lab</em> <em>Limited</e[+325 characters]",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zai</em> <em>Lab</em> and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"sentiment": -0.7906,
"highlighted_in": "title"
}
]
},
{
"symbol": "9688.HK",
"name": "Zai Lab Limited",
"exchange": null,
"exchange_long": null,
"country": "hk",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.170288,
"sentiment_score": -0.7196,
"highlights": [
{
"highlight": "<em>Zai</em> <em>Lab</em> <em>Limited</e[+325 characters]",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zai</em> <em>Lab</em> and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News",
"sentiment": -0.7906,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "cc2bd2c4-c7a3-4c24-a4ca-dbd6dfeafdf1",
"title": "Regeneron Pharmaceuticals, Inc. (REGN) Shares Plunge Despite Positive Phase 3 Itepekimab Results",
"description": "Regeneron Pharmaceuticals, Inc.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/regeneron-pharmaceuticals-inc-regn-shares-plunge-despite-positive-phase-3-itepekimab-results-1545346/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/23055613/REGN-insidermonkey-1695462971092.jpg",
"language": "en",
"published_at": "2025-06-01T00:18:16.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 126.86215,
"sentiment_score": 0.1124,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em>, <em>Inc</em>. (REGN) Shares Plunge Despite Positive Phase 3 Itepekimab Results",
"sentiment": 0.1124,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "c2c00b48-3354-432b-8439-ea618b546552",
"title": "Tempus AI, Inc. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics",
"description": "Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a groundbreaking initiative set to transform precision medicine.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/tempus-ai-inc-tem-launches-fuses-to-power-ai-driven-precision-diagnostics-1545348/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2024/12/13182429/A-creative-representation-of-artificial-intelligence-and-the-stock-market-showcasing-an-abstract-digital-brain-with-interconnect.webp",
"language": "en",
"published_at": "2025-06-01T00:14:37.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "TEM",
"name": "Tempus AI Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 115.63982,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Tempus</em> <em>AI</em>, <em>Inc</em>. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "5b4f9d9b-3391-4487-83b7-9a32ae1e45b3",
"title": "Tempus AI hits back at scathing short report",
"description": "The health care AI startup has responded to some scathing accusations.",
"keywords": "Spruce Point, Eric Lefkofsky, Tempus, AI capabilities, TEM",
"snippet": "Tempus AI hits back at scathing short report originally appeared on TheStreet.\n\nOn May 28, Tempus AI (TEM) stock plunged as the market reacted to a damning repo...",
"url": "https://finance.yahoo.com/news/tempus-ai-hits-back-scathing-173300335.html",
"image_url": "https://media.zenfs.com/en/thestreet_881/59efe6851e5b960ad96244306185f32b",
"language": "en",
"published_at": "2025-05-31T17:33:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "TEM",
"name": "Tempus AI Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 62.92681,
"sentiment_score": -0.190633,
"highlights": [
{
"highlight": "<em>Tempus</em> <em>AI</em> hits back at[+266 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tempus</em> <em>AI</em> and CEO Eric[+334 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tempus</em> <em>AI</em> hits back at scathing short report",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "00e026cc-46cc-4e03-976b-f38696b46180",
"title": "Gilead Sciences, Inc, (GILD)’s Trodelvy and Merck & Co., Inc, (MRK)’s Keytruda Cuts Breast Cancer Progression Risk by 35%",
"description": "A new clinical trial has shown that combining Gilead Sciences, Inc. (NASDAQ:GILD)’s Trodelvy with Merck & Co., Inc.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/gilead-sciences-inc-gilds-trodelvy-and-merck-co-inc-mrks-keytruda-cuts-breast-cancer-progression-risk-by-35-1545353/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/15133953/LGMK-insidermonkey-1702665591422.jpg",
"language": "en",
"published_at": "2025-06-01T00:11:43.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.61472,
"sentiment_score": -0.8271,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em>, <em>Inc</em>, (GILD)’s Trodelvy and Merck & Co., Inc, (MRK)’s Keytruda Cuts Breast Cancer Progression Risk by 35%",
"sentiment": -0.8271,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.60211,
"sentiment_score": -0.8271,
"highlights": [
{
"highlight": "Gilead Sciences, Inc, (GILD)’s Trodelvy and <em>Merck</em> & <em>Co</em>., <em>Inc</em>, (MRK)’s Keytruda Cuts Breast Cancer Progression Risk by 35%",
"sentiment": -0.8271,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5da39d33-008c-41b5-9675-ca1066dff941",
"title": "Guardant Health, Inc. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients",
"description": "Guardant Health, Inc.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/guardant-health-inc-ghs-ctdna-test-predicts-colon-cancer-recurrence-risk-in-stage-iii-patients-1545357/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/10/01172653/GH-insidermonkey-1696195611334.jpg",
"language": "en",
"published_at": "2025-06-01T00:08:44.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "GH",
"name": "Guardant Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 109.81819,
"sentiment_score": -0.7579,
"highlights": [
{
"highlight": "<em>Guardant</em> <em>Health</em>, <em>Inc</em>. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients",
"sentiment": -0.7579,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "634967f3-9d01-49c6-a965-10b3989c3c76",
"title": "AbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic Dermatitis",
"description": "Vancouver-based biotech firm AbCellera Biologics Inc. (NASDAQ:ABCL) has announced a major milestone in its fight against atopic dermatitis (AD).",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/abcellera-biologics-inc-abcl-approved-to-begin-abcl575-trial-for-atopic-dermatitis-1545002/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/11/02223623/PBYI-insidermonkey-1698978981566.jpg",
"language": "en",
"published_at": "2025-05-31T23:55:44.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABCL",
"name": "AbCellera Biologics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 151.6867,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "<em>AbCellera</em> <em>Biologics</em> <em>Inc</em>. (ABCL) Approved to Begin ABCL575 Trial for Atopic Dermatitis",
"sentiment": 0.4215,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "740246f2-314a-4768-b171-5bcddd821405",
"title": "Kymera Therapeutics, Inc. (KYMR) to Announce KT-621 Phase 1 Results on June 2, 2025",
"description": "Kymera Therapeutics, Inc. (NASDAQ:KYMR) is set to unveil results from its Phase 1 clinical trial of KT-621, a first-in-class oral STAT6 degrader, on Monday, June 2, 2025.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nAI i...",
"url": "https://www.insidermonkey.com/blog/kymera-therapeutics-inc-kymr-to-announce-kt-621-phase-1-results-on-june-2-2025-1544988/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/09075839/IPHA-insidermonkey-1702126718038.jpg",
"language": "en",
"published_at": "2025-05-31T23:53:26.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "KYMR",
"name": "Kymera Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 121.31947,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Kymera</em> <em>Therapeutics</em>, <em>Inc</em>. (KYMR) to Announce KT-621 Phase 1 Results on June 2, 2025",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "102df7fa-3fd1-47e5-90d5-1a34a6bf6ac7",
"title": "Be a More Diversified, High Dividend, Low Payout Dividend Investor.",
"description": "My friend STE shared with us this pretty good piece by Hartford Financial Group on the case for dividend investing. The Power of Dividends: Past, Present, and Future I think STE appreciates that while we are successful",
"keywords": "",
"snippet": "My friend STE shared with us this pretty good piece by Hartford Financial Group on the case for dividend investing.\n\nThe Power of Dividends: Past, Present, and ...",
"url": "https://investmentmoats.com/money-management/dividend-investing/be-a-more-diversified-high-dividend-low-payout-dividend-investor/",
"image_url": "https://investmentmoats.com/wp-content/uploads/2025/05/20250531-The-Power-of-Dividends_-Past-Present-and-Future-9.png",
"language": "en",
"published_at": "2025-05-31T23:22:33.000000Z",
"source": "investmentmoats.com",
"relevance_score": null,
"entities": [
{
"symbol": "SYLD",
"name": "Cambria Shareholder Yield ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 30.042595,
"sentiment_score": 0.0772,
"highlights": [
{
"highlight": "This gives rise to factor funds like SYL[+336 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "6bdc9250-221c-421a-ac25-c4c944949130",
"title": "Warren Buffett Will Make Over $1.33 Billion This Year From Investing in These 2 High-Yielding Dividend Stocks",
"description": "Warren Buffett's company Berkshire Hathaway owns several stocks with strong dividends. Dividend stocks can be nice to own because they often provide reliable, passive income, even during volatile markets. Warren Buffett and his company, Berkshire Hathaway, have never paid a dividend, primarily because Buffett has always believed that he could deploy capital in a more rewarding manner for shareholders.",
"keywords": "Warren Buffett, Berkshire Hathaway, Kraft Heinz, Dividend stocks, passive income, Chevron, Free cash flow",
"snippet": "Key Points\n\nWarren Buffett's company Berkshire Hathaway owns several stocks with strong dividends.\n\nDividend stocks can be nice to own because they often provid...",
"url": "https://finance.yahoo.com/news/warren-buffett-over-1-33-221400526.html",
"image_url": "https://s.yimg.com/ny/api/res/1.2/J8dw0iMlB8l6QFwzXqHT8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/7236defcc2ad3d91f905333e08d73f5f",
"language": "en",
"published_at": "2025-05-31T22:14:00.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "BRK-B",
"name": "Berkshire Hathaway Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 24.848423,
"sentiment_score": 0.71175,
"highlights": [
{
"highlight": "Key Points\n\nWarren Buffett's company <em[+76 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Dividend stocks can be nice to own becau[+338 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRK-A",
"name": "Berkshire Hathaway Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 24.848423,
"sentiment_score": 0.71175,
"highlights": [
{
"highlight": "Key Points\n\nWarren Buffett's company <em[+76 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Dividend stocks can be nice to own becau[+338 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CVX",
"name": "Chevron Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 32.039486,
"sentiment_score": 0.4713,
"highlights": [
{
"highlight": "Dividend stocks can be nice to own becau[+329 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chevron</em>: $811 million in annual[+295 characters]",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "This thesis has led Berkshire to purchas[+284 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chevron</em> has paid a quarterly di[+294 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Chevron</em> increased its quarterly[+107 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ORCL",
"name": "Oracle Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.40238,
"sentiment_score": 0.6073,
"highlights": [
{
"highlight": "Over six decades, the <em>Oracle</em> of[+302 characters]",
"sentiment": 0.6073,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 39.56359,
"sentiment_score": 0.71175,
"highlights": [
{
"highlight": "Key Points\n\nWarren Buffett's company <em[+76 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Dividend stocks can be nice to own becau[+338 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBD.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 39.56359,
"sentiment_score": 0.71175,
"highlights": [
{
"highlight": "Key Points\n\nWarren Buffett's company <em[+76 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Dividend stocks can be nice to own becau[+338 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRKBB.BA",
"name": "BERKSHIRE HATHAWAY",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 39.56359,
"sentiment_score": 0.71175,
"highlights": [
{
"highlight": "Key Points\n\nWarren Buffett's company <em[+76 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Dividend stocks can be nice to own becau[+338 characters]",
"sentiment": 0.9129,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 419,
"sentiment_avg": 0.26831171160051953
}
]
}
Other details
Entity count
- 32,649